Azoulay et al developed a predictive model for Pneumocystis jirovecii pneumonia (PJP) in a patient with a hematologic malignancy and acute respiratory failure. The authors are from multiple institutions in France.
Patient selection: hematologic malignancy and acute respiratory failure
Parameters:
(1) age in years
(2) diagnosis
(3) PJP prophylaxis
(4) number of days between onset of respiratory symptoms and ICU admission
(5) shock on ICU admission
(6) chest X-ray findings
(7) pleural effusion
Parameter |
Finding |
Points |
age in years |
< 50 years |
0 |
|
50 to 70 years |
-1.5 |
|
> 70 years |
-2.5 |
diagnosis |
lymphoproliferative disorder |
2 |
|
other |
0 |
PJP prophylaxis |
no |
1 |
|
yes |
0 |
days between onset and ICU admission |
< 3 days |
0 |
|
3 to 5 days |
3 |
|
> 5 days |
3 |
shock on ICU admission |
no |
0 |
|
yes |
-1.5 |
chest X-ray |
alveolar |
0 |
|
non-alveolar |
2.5 |
pleural effusion |
no |
0 |
|
yes |
-2 |
total score =
= SUM(points for all 7 parameters)
Interpretation:
• minimum score: -6
• maximum score: 8.5
• A score >= 3 had a sensitivity of 87% and specificity of 68%. The negative predictive value was 98% at a 10% prevalence.
Performance:
• The area under the ROC curve is 0.80 in derivation cohort and 0.83 in the validation cohort.
Specialty: Infectious Diseases